Market Watch
· May 1, 2026 1:57 PM EDT
Not market news
Can GLP-1s curb alcohol use? A new study says the drugs can reduce heavy drinking.
A “gold standard” trial found that semaglutide helped reduce drinking in people with obesity who sought out treatment for alcohol-use disorder.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief